Burn Treatment
NDC 49687-0014, BENZALKONIUM CHLORIDE, LIDOCAINE HYDROCHLORIDE, cream, from CMC Group Inc..
- Product NDC
- 49687-0014
- Status
- Listed
- Labeler
- CMC Group Inc.
- Dosage form
- CREAM
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M003
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/49687-0014 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BENZALKONIUM CHLORIDE.13 g/100g
- LIDOCAINE HYDROCHLORIDE.5 g/100g
Pharmacologic classes
Amide Local Anesthetic [EPC]; Amides [CS]; Antiarrhythmic [EPC]; Local Anesthesia [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 49687-0014-0 | 49687001400 | 10 POUCH in 1 KIT (49687-0014-0) / .9 g in 1 POUCH |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 49687-0014 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/49687-0014 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 49687-0014. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.